Workflow
JAK1 Receptor Inhibition
icon
搜索文档
EyePoint Pharmaceuticals(EYPT) - 2025 Q4 - Earnings Call Transcript
2026-03-04 22:32
EyePoint Pharmaceuticals (NasdaqGM:EYPT) Q4 2025 Earnings call March 04, 2026 08:30 AM ET Company ParticipantsClara Dong - VP of Equity Research in BiotechnologyGeorge Elston - EVP, CFO, and Head of Corporate DevelopmentGraig Suvannavejh - Managing DirectorJay Duker - President and CEOLisa Walter - VPMichael Campbell - Chief Commercial OfficerRamiro Ribeiro - Chief Medical OfficerYigal Nochomovitz - DirectorConference Call ParticipantsColleen Kusy - Director and Senior Equity Research AnalystDaniil Gataulin ...